Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.

Maxime Look, Wim Putten, MJ Duffy, N Harbeck, IJ Christensen, C Thomssen, R Kates, F Spyratos, M Fernö, S Eppenberger-Castori, CGJ Sweep, K Ulm, J-P Peyrat, PM Martin, H Magdelenat, N Brüner, C Duggan, BW Lisboa, P-O Bendahl, V QuillienA Daver, G Ricolleau, M Meijer - Gelder, P Manders, WE Fiets, MA Blankenstein, P Brot, G Daxenbichler, G Windbichler, T Cufer, S Borstnar, W Kueng, LVAM Beex, Jan Klijn, N O' Higgins, U Eppenberger, F Jäicke, M Schmitt, John Foekens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)116-128
Number of pages13
JournalJournal of the National Cancer Institute
Volume94
Issue number2
Publication statusPublished - 2002

Cite this